Skip to main content
. 2019 Dec 4;33(5):905–915. doi: 10.1038/s41379-019-0418-2

Fig. 4. Univariable results of recurrence related to cytoplasmic BUB3 scores combined with cyclin B1 (CCNB1) scores.

Fig. 4

Valid results for both cytoplasmic BUB3 and CCNB1 were obtained for 239 patients. A tumor was considered positive or negative when a tumor was positive or negative for both of the proteins. Heterogeneous scores, where the tumors were positive for either cytoplasmic BUB3 or CCNB1, was observed in 96 patients. Recurrence was defined as locoregional recurrence, metastasis, or death from prostate cancer. The 95% confidence intervals of the hazard ratio (HR) are listed in parentheses.